Prognostic value of α-fetoprotein and des-γ-carboxy prothrombin responses in patients with hepatocellular carcinoma treated with transarterial chemoembolization
<p>Abstract</p> <p>Background/Aims</p> <p>Alpha-fetoprotein (AFP) and des-gamma-carboxy prothrombin (DCP) have been used as diagnostic tools for hepatocellular carcinoma (HCC). However, prediction of outcome using AFP and DCP has not been elucidated. We investigated the...
Main Authors: | Lee Yong Kang, Kim Seung Up, Kim Do Young, Ahn Sang Hoon, Lee Kwang Hun, Lee Do Yun, Han Kwang-Hyub, Chon Chae Yoon, Park Jun Yong |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2013-01-01
|
Series: | BMC Cancer |
Subjects: | |
Online Access: | http://www.biomedcentral.com/1471-2407/13/5 |
Similar Items
-
Next-generation des-r-carboxy prothrombin for immunohistochemical assessment of vascular invasion by hepatocellular carcinoma
by: Shintaro Yamazaki, et al.
Published: (2020-09-01) -
Baseline Alpha-Fetoprotein, Alpha-Fetoprotein-L3, and Des-Gamma-Carboxy Prothrombin Biomarker Status in Bridge to Liver Transplant Outcomes for Hepatocellular Carcinoma
by: Kelley G. Núñez, et al.
Published: (2021-09-01) -
Prognosis of Patients with Hepatocellular Carcinoma Treated with Transarterial Chemoembolization(MC-hccAI 001): Development and Validation of the ALFP Score
by: Gong B, et al.
Published: (2023-08-01) -
Alpha-Fetoprotein Response after First Transarterial Chemoembolization (TACE) and Complete Pathologic Response in Patients with Hepatocellular Cancer
by: Łukasz Masior, et al.
Published: (2023-08-01) -
Prognostic Values of Alpha-Fetoprotein and Des-Gamma-Carboxyprothrombin in Hepatocellular Carcinoma in China: An Analysis of 4792 Patients
by: Pan YX, et al.
Published: (2021-06-01)